153 related articles for article (PubMed ID: 31145254)
21. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
22. What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides?
Alfawaz HA; Aljumah AA
Saudi J Gastroenterol; 2012; 18(3):153-4. PubMed ID: 22626793
[No Abstract] [Full Text] [Related]
23. Use of Lactulose in Hepatic Encephalopathy: Is It Time to Shift Targets?
Sharma S; Chauhan A
Clin Gastroenterol Hepatol; 2022 May; 20(5):e1220-e1221. PubMed ID: 34058412
[No Abstract] [Full Text] [Related]
24. Optimal treatment of hepatic encephalopathy.
Waghray A; Waghray N; Kanna S; Mullen K
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
[TBL] [Abstract][Full Text] [Related]
25. [Hepatic encephalopathy – the acute management].
Wahlin S
Lakartidningen; 2016 Mar; 113():. PubMed ID: 26978809
[TBL] [Abstract][Full Text] [Related]
26. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.
Horsmans Y; Solbreux PM; Daenens C; Desager JP; Geubel AP
Aliment Pharmacol Ther; 1997 Feb; 11(1):165-70. PubMed ID: 9042989
[TBL] [Abstract][Full Text] [Related]
27. A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy.
Hasan S; Datta S; Bhattacherjee S; Banik S; Saha S; Bandyopadhyay D
J Assoc Physicians India; 2018 Jan; 66(1):32-6. PubMed ID: 30341842
[TBL] [Abstract][Full Text] [Related]
28. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
29. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy.
Neff GW; Kemmer N; Zacharias VC; Kaiser T; Duncan C; McHenry R; Jonas M; Novick D; Williamson C; Hess K; Thomas M; Buell J
Transplant Proc; 2006 Dec; 38(10):3552-5. PubMed ID: 17175328
[TBL] [Abstract][Full Text] [Related]
30. [Hepatic encephalopathy -- preventative effects of lactulose].
Z Gastroenterol; 2013 Aug; 51(8):708. PubMed ID: 24298621
[No Abstract] [Full Text] [Related]
31. Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics.
Dasarathy S
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S50-3. PubMed ID: 15025256
[TBL] [Abstract][Full Text] [Related]
32. Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality.
Jia JD
J Gastroenterol Hepatol; 2012 Aug; 27(8):1262-3. PubMed ID: 22823914
[No Abstract] [Full Text] [Related]
33. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
[No Abstract] [Full Text] [Related]
34. Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy?
Butt NI; Butt UI; Kakar AATK; Malik T; Siddiqui AM
J Coll Physicians Surg Pak; 2018 Feb; 28(2):115-117. PubMed ID: 29394969
[TBL] [Abstract][Full Text] [Related]
35. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
36. A possible case of minimal hepatic encephalopathy treated successfully with lactulose.
Spiegel DR; Surkin K
J Neuropsychiatry Clin Neurosci; 2011; 23(1):E1. PubMed ID: 21304108
[No Abstract] [Full Text] [Related]
37. Improving treatments for hepatic encephalopathy.
Gastroenterol Nurs; 2012; 35(4):291-2. PubMed ID: 22847290
[No Abstract] [Full Text] [Related]
38. [Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy].
Nie YQ; Zeng Z; Li YY; Sha WH; Ping L; Dai SJ
Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):261-3. PubMed ID: 12887812
[TBL] [Abstract][Full Text] [Related]
39. Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence.
Hudson M; Schuchmann M
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):434-450. PubMed ID: 30444745
[TBL] [Abstract][Full Text] [Related]
40. Erratum: Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrencey.
Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38934704
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
